Cargando…
Simultaneous reduction of flow and fraction of inspired oxygen (FiO(2)) versus reduction of flow first or FiO(2) first in patients ready to be weaned from high-flow nasal cannula oxygen therapy: study protocol for a randomized controlled trial (SLOWH trial)
BACKGROUND: High-flow nasal cannula (HFNC) oxygen therapy has been widely used in critically ill patients. Despite the effectiveness of HFNC as a treatment, optimal methods to withdraw HFNC after recovery from preexisting conditions have not been investigated to date. In this study, we will evaluate...
Autores principales: | Kim, Min Chul, Lee, Yeon Joo, Park, Jong Sun, Cho, Young-Jae, Yoon, Ho Il, Lee, Choon-Taek, Lee, Jae Ho, Kim, Eun Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961313/ https://www.ncbi.nlm.nih.gov/pubmed/31937322 http://dx.doi.org/10.1186/s13063-019-4019-7 |
Ejemplares similares
-
SpO(2)/FiO(2) as a predictor of high flow nasal cannula outcomes in children with acute hypoxemic respiratory failure
por: Kim, Ga Eun, et al.
Publicado: (2021) -
Association between SpO(2)/FiO(2) Ratio and PaO(2)/FiO(2) Ratio in Different Modes of Oxygen Supplementation
por: Babu, Sheetal, et al.
Publicado: (2021) -
Variation in the PaO(2)/FiO(2 )ratio with FiO(2): mathematical and experimental description, and clinical relevance
por: Karbing, Dan S, et al.
Publicado: (2007) -
Relation between PaO(2)/FiO(2 )ratio, SpO(2)/FiO(2 )ratio, oxygenation index and ventilation ratio in critically ill patients
por: Aslanidis, T, et al.
Publicado: (2013) -
Correlation of SpO(2)/FiO(2) and PaO(2)/FiO(2) in patients with symptomatic COVID-19: An observational, retrospective study
por: Bonaventura, Aldo, et al.
Publicado: (2022)